Jayson Donald Alexander Dallas's Net Worth

$6.02 Million

Estimate Recalculated Nov 1, 2024 04:00AM EST

Who is Jayson Donald Alexander Dallas?

Jayson Donald Alexander Dallas has an estimated net worth of $6.02 Million. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, Ultragenyx Pharmaceutical Inc., Galecto, Inc., and Aimmune Therapeutics, Inc..

SEC CIK

Jayson Donald Alexander Dallas's CIK is 0001650322

Past Insider Trading and Trends

2020 was Jayson Donald Alexander Dallas's most active year for acquiring shares with 10 total transactions. Jayson Donald Alexander Dallas's most active month to acquire stocks was the month of May. 2022 was Jayson Donald Alexander Dallas's most active year for disposing of shares, totalling 9 transactions. Jayson Donald Alexander Dallas's most active month to dispose stocks was the month of February. 2018 saw Jayson Donald Alexander Dallas paying a total of $100,586.80 for 461,631 shares, this is the most they've acquired in one year. In 2020 Jayson Donald Alexander Dallas cashed out on 892,302 shares for a total of $10,139,565.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ARENA PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-7.15K
—
—
0
Mar 11
Form 4
+34.74%
1.84K
$66.36
-$81,158.28
7.15K
Scheduled
Jun 11 - Jun 15
Form 4
-20.00%
-1.33K
$80.50
-$106,823.50
5.31K
Scheduled
Jan 19
Form 4
+0.08%
5
$69.31
$346.55
6.63K
Dec 11
Form 4
+0.08%
5
$66.25
$331.24
6.63K
Dec 8
Form 4
+58.53%
2.45K
—
—
6.63K
Jun 12
Form 4
+37.02%
1.13K
$55.90
-$85,240.33
4.18K
Scheduled
Jun 13 - Jun 14
Form 4
∞
3.05K
—
—
3.05K
Jun 13
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Feb 13
Form 3
—
0
—
—
0
No matching records found

Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $55.24

EVP & Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.22%
-294.00
$73.73
-$21,676.62
23.83K
Jun 1
Form 4
+6.45%
1.43K
—
—
23.6K
Apr 19
Form 4
+37.60%
6.06K
$48.43
-$21,357.63
22.17K
Mar 1
Form 4
-5.51%
-940.00
$62.59
-$58,834.60
16.11K
Aug 3
Form 4
-1.84%
-320.00
$56.61
-$18,115.20
17.05K
Jun 1
Form 4
+36.12%
4.5K
—
—
16.96K
Mar 1
Form 4
-7.01%
-940.00
$64.24
-$60,385.60
12.46K
Aug 4
Form 4
—
0
—
—
0
Jun 3
Form 4
+34.00%
3.4K
—
—
13.4K
Jun 1
Form 4
∞
10K
—
—
10K
Aug 4
Form 3
—
0
—
—
0
No matching records found

Galecto, Inc. (GLTO) Snapshot price: $11.41

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
Nov 19
Form 3
—
0
—
—
0
No matching records found

Aimmune Therapeutics, Inc. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-119.67K
$34.50
-$4,128,684.00
0
Oct 10 - Oct 13
Form 4
-1.38%
-1.64K
$34.25
-$56,238.50
117.03K
Sep 15
Form 4
-6.25%
-7.91K
$18.02
-$142,484.14
118.68K
Jun 22
Form 4
+2.68%
3.3K
—
—
126.58K
May 10
Form 4
+2.21%
2.67K
$18.74
$49,934.11
123.28K
Mar 10
Form 4
-2.49%
-3.08K
$23.81
-$73,358.61
120.62K
Mar 2
Form 4
+36.38%
33K
—
—
123.7K
Feb 28
Form 4
+54.99%
35K
—
—
98.65K
Feb 22
Form 4
+6.08%
3.65K
$27.56
$100,586.80
63.65K
Nov 19
Form 4
∞
60K
—
—
60K
Jun 19
Form 3
—
0
—
—
0
No matching records found